The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases

心脏、肺、血液和睡眠疾病护理点推进中心

• 批准号: 10222761
• 负责人: BRYAN O BUCHHOLZ
• 金额: $ 156.25万
• 依托单位: UNIV OF MASSACHUSETTS MED SCH WORCESTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-08-22 至 2023-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10222761
• 关键词: Address; Adoption; Affect; American; Automobile Driving; Blood; Businesses; Cardiovascular system; Caregivers; Caring; Cessation of life; Clinic; Clinical; Detection; Development; Device or Instrument Development; Diagnosis; Disease; Engineering; Family Caregiver; Feedback; Funding; Goals; Health; Healthcare; Heart; Heart Diseases; Heart failure; Hematological Disease; Income; Incubators; Intervention; Knowledge; Lead; Life; Lung; Lung diseases; Massachusetts; Medical; Medical Device; Mentors; Modeling; Monitor; Morbidity - disease rate; Outpatients; Participant; Pathway interactions; Patients; Physicians; Point of Care Technology; Policy Maker; Preventive measure; Process; Provider; Quality of life; Reporting; Resources; Role; Self Care; Sleep; Sleep Disorders; Symptoms; System; Technology; Time; Training; Training Programs; Universities; Vision; acute care; bundled payment; clinical development; commercialization; cost; evidence base; hospital readmission; hypertension control; improved; industry partner; medical schools; mortality; novel; point of care; precision medicine; programs; research clinical testing; success; technology development; tool; trend; user-friendly

PROJECT SUMMARY/ABSTRACT - OVERALL American healthcare is rapidly evolving to a state where efficiency and quality in health care are co-dominant drivers. Several emergent trends are driving fundamental changes in health care: 1) increasing numbers of patients in accountable care organizations with bundled payments to providers; 2) emphasis on quality metrics such as reducing readmissions for heart failure and improving control of hypertension; and 3) increasing focus on the patient as a driver of medical decisions and a partner in care. There is now an urgent need to develop technologies that provide rapid feedback to both caregivers and patients in order to effect timely changes in patient self-care, symptom detection, diagnosis and treatment delivery. In particular, there is a critical need for new evidence-based, user-friendly, patient-centric, point-of-care technologies (POCT) to monitor health/medical status in people as they go about their daily lives out of the clinic and to deliver actionable reports to the point of care. The Center for Advancing Point of Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Diseases will be an offshoot of a highly successful medical product incubator, the Massachusetts Medical Device Development Center (M2D2) at the University of Massachusetts (Lowell and Worcester campuses). The founding goal of M2D2 was to accelerate the development of medical devices, using the combined expertise of UMass Lowell (UML) in engineering and business, and the clinical expertise of UMass Medical School (UMMS) in Worcester. Expanding upon the vision and success of M2D2, the goal of CAPCaT is to develop and optimize novel POCT to improve the diagnosis and management of heart, lung, blood and sleep (HLBS) diseases. We have focused on these diseases because of the significant morbidity, mortality, and cost associated with these diseases. Combined, these diseases account for 41% of deaths in the US and lead to over $400B in direct health care expenses plus lost income to affected patients and caregivers. UMass has an established track record of clinical expertise and technology development in the HLBS diseases. Our objectives are to: 1) identify, through stakeholder engagement, the most promising POCTs to address unmet medical needs; 2) support developmental plans, including pathways to adoption at the point of care; and 3) train and disseminate developing POCT to the different stakeholders.

项目概要/摘要 - 总体 美国医疗保健正在迅速发展到医疗保健效率和质量都很高的状态 共同主导的驱动因素。一些新兴趋势正在推动医疗保健领域发生根本性变化： 1) 越来越多的患者在责任医疗组织中接受捆绑付款 提供商； 2) 强调质量指标，例如减少心力衰竭的再入院率和 改善高血压的控制； 3) 日益关注患者作为医疗的推动者 决策和护理伙伴。现在迫切需要开发技术 向护理人员和患者提供快速反馈，以便及时做出改变 患者自我护理、症状检测、诊断和治疗。特别地，有一个 迫切需要新的基于证据的、用户友好的、以患者为中心的即时护理技术 (POCT) 监测人们日常生活中的健康/医疗状况 诊所并向护理点提供可操作的报告。推进点中心 心脏、肺、血液和睡眠疾病领域的护理技术 (CAPCaT) 将是 非常成功的医疗产品孵化器，马萨诸塞州医疗器械开发中心 马萨诸塞大学（洛厄尔和伍斯特校区）的中心 (M2D2)。这 M2D2 的创立目标是利用 结合了麻省大学洛厄尔分校 (UML) 在工程和商业以及临床方面的专业知识 伍斯特麻省大学医学院 (UMMS) 的专业知识。扩展愿景和 M2D2 的成功，CAPCaT 的目标是开发和优化新型 POCT，以提高 心、肺、血液和睡眠 (HLBS) 疾病的诊断和管理。我们专注于 由于与这些疾病相关的显着发病率、死亡率和费用 疾病。这些疾病加起来占美国死亡人数的 41%，并导致超过 $400B 的直接医疗保健费用加上受影响的患者和护理人员的收入损失。 麻省大学在临床专业知识和技术开发方面拥有良好的记录 HLBS 疾病。我们的目标是： 1) 通过利益相关者的参与，确定最 有望通过 POCT 解决未满足的医疗需求； 2）支持发展计划，包括 在护理点收养的途径； 3) 向相关人员培训和传播正在开发的 POCT 不同的利益相关者。